We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.2B
1-Year Est. Return 38.92%
This Fund
S&P 500
This Quarter Est. Return
+9.6%
1 Year Est. Return
+38.92%
3 Year Est. Return
+73.78%
5 Year Est. Return
+108.79%
10 Year Est. Return
+308.35%
AUM
$7.5B
AUM Growth
+$173M
Cap. Flow
-$464M
Cap. Flow %
-6.18%
Top 10 Hldgs %
35.15%
Holding
108
New
6
Increased
13
Reduced
69
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 28.16%
2 Energy 17.88%
3 Communication Services 15.97%
4 Materials 11.88%
5 Technology 7.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPA icon
76
Copa Holdings
CPA
$5.8B
$12.4M 0.17%
165,000
BAP icon
77
Credicorp
BAP
$30.7B
$12.1M 0.16%
100,025
+13,000
+15% +$1.7M
CVE.WS
78
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$9.55M 0.13%
1,764,718
-53,059
-3% -$244K
GT icon
79
Goodyear
GT
$1.85B
$8.38M 0.11%
488,808
-119,550
-20% -$2.2M
FLR icon
80
Fluor
FLR
$7.96B
$6.7M 0.09%
378,669
-38,225
-9% -$788K
PDS
81
Precision Drilling
PDS
$974M
$6.31M 0.08%
151,177
-35,799
-19% -$1.11M
FTS icon
82
Fortis
FTS
$28.7B
$6.3M 0.08%
142,125
+3,075
+2% +$139K
YTRA icon
83
Yatra Online
YTRA
$52.6M
$4.83M 0.06%
2,138,020
VT icon
84
Vanguard Total World Stock ETF
VT
$79.8B
$1.89M 0.03%
18,200
-60,700
-77% -$6.19M
SCHW
85
Charles Schwab
SCHW
$187B
$1.59M 0.02%
21,846
MYOV
86
DELISTED
Myovant Sciences Ltd.
MYOV
$1.44M 0.02%
63,204
ING icon
87
ING
ING
$102B
$1.41M 0.02%
106,275
-3,594
-3% -$47.1K
ARDX icon
88
Ardelyx
ARDX
$988M
$1.31M 0.02%
172,300
OM icon
89
Outset Medical
OM
$90.8M
$1.13M 0.02%
+1,500
New +$1.15M
SPRO icon
90
Spero Therapeutics
SPRO
$73M
$1.03M 0.01%
73,659
HRTX icon
91
Heron Therapeutics
HRTX
$92.9M
$888K 0.01%
57,200
REPL icon
92
Replimune Group
REPL
$1.01B
$876K 0.01%
22,800
MET icon
93
MetLife
MET
$62.4B
$784K 0.01%
13,099
UNH icon
94
UnitedHealth
UNH
$370B
$741K 0.01%
1,850
QNCX icon
95
Quince Therapeutics
QNCX
$29.5M
$502K 0.01%
47
IMV
96
DELISTED
IMV Inc. Common Shares
IMV
$368K ﹤0.01%
17,000
ONCR
97
DELISTED
Oncorus, Inc.
ONCR
$342K ﹤0.01%
24,750
+5,000
+25% +$77.2K
E icon
98
ENI
E
$77.5B
$317K ﹤0.01%
13,000
RDS.B
99
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$307K ﹤0.01%
7,912
DUK icon
100
Duke Energy
DUK
$97.3B
$306K ﹤0.01%
3,100

Similar funds

Letko, Brosseau & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Letko, Brosseau & Associates held 108 positions worth $7.5B, up 2.4% from $7.33B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Letko, Brosseau & Associates withdrew a net $464M in Q2 2021, closing 2 positions and reducing 69 holdings. Its most notable exit was Brookfield Property Partners L.P. Limited Partnership Units, an estimated $72M position sold in full.

By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Energy and Communication Services.

Against the trend, Letko, Brosseau & Associates opened a new position in Companhia Paranaense de Energia (COPEL) worth $35.4M.

  • Letko, Brosseau & Associates's largest Q2 2021 buy was Companhia Paranaense de Energia (COPEL): 7,679,175 shares worth $35.4M.
  • Letko, Brosseau & Associates added most to Pfizer in Q2 2021, an estimated $30.9M increase.
  • Letko, Brosseau & Associates's biggest Q2 2021 reduction was West Fraser Timber, cutting an estimated $34.3M.
  • Letko, Brosseau & Associates fully exited Brookfield Property Partners L.P. Limited Partnership Units in Q2 2021, selling an estimated $72M.
  • Letko, Brosseau & Associates's ten largest holdings make up 35% of its $7.5B portfolio in Q2 2021.
  • Letko, Brosseau & Associates opened 6 new positions and closed 2 in Q2 2021.
  • Letko, Brosseau & Associates's portfolio value rose 2.4% quarter-over-quarter to $7.5B.

Based on Letko, Brosseau & Associates's 13F filing for Q2 2021, filed 29 Jul 2021.